Mereo BioPharma Group plc Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2023 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Mereo BioPharma Group plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2023 to Q2 2024.
  • Mereo BioPharma Group plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 712M shares, a 13.3% increase year-over-year.
  • Mereo BioPharma Group plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 659M shares, a 9.33% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 712M +83.3M +13.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 700M +76.3M +12.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q2 2023 628M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 624M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.